Astera Labs (NASDAQ:ALAB) Shares Down 1.4% – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price was down 1.4% during trading on Friday . The company traded as low as $193.25 and last traded at $197.78. Approximately 3,309,038 shares changed hands during mid-day trading, a decline of 35% from the average daily volume of 5,120,711 shares. The stock had previously closed at $200.64.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Needham & Company LLC lifted their target price on shares of Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Susquehanna boosted their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the stock a “neutral” rating in a report on Thursday, August 7th. Barclays restated an “overweight” rating and set a $155.00 price objective (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a report on Saturday, August 16th. Finally, Evercore ISI boosted their price objective on shares of Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $152.94.

Astera Labs Price Performance

The firm has a market capitalization of $32.87 billion, a P/E ratio of 353.18, a P/E/G ratio of 5.02 and a beta of 1.48. The stock’s 50 day moving average is $181.88 and its two-hundred day moving average is $114.97.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs’s revenue for the quarter was up 149.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the sale, the director owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the completion of the transaction, the general counsel owned 161,573 shares of the company’s stock, valued at $30,488,825.10. This trade represents a 5.83% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,576,027 shares of company stock valued at $239,177,011. Corporate insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

Large investors have recently added to or reduced their stakes in the company. Fred Alger Management LLC raised its position in shares of Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after purchasing an additional 179,638 shares during the period. Hoey Investments Inc. boosted its stake in shares of Astera Labs by 22.4% in the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock valued at $553,000 after purchasing an additional 1,121 shares in the last quarter. Wealth Effects LLC acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $242,000. Sheets Smith Wealth Management acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $481,000. Finally, Aigen Investment Management LP boosted its position in Astera Labs by 50.9% during the 1st quarter. Aigen Investment Management LP now owns 17,920 shares of the company’s stock worth $1,069,000 after buying an additional 6,045 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.